Southridge Partners II enters into a $10 million equity purchase agreement with mBeach Software, Inc.
August 31, 2011

RIDGEFIELD, CT, August 31, 2011 – Stephen Hicks, Managing Member of Southridge, announced today that Southridge Partners II LP ("Southridge"), an institutional investor, has entered into a $10 million equity purchase agreement with mBeach Software, Inc. mBeach Software, Inc. (OTCBB:MBHS), a Florida corporation, through its wholly owned subsidiary Skin Cancer Scanning Ltd. ("SCS"), is currently developing the SkinScan 650, a non-invasive, point-of-care medical device system to be used in physicians' clinics to diagnose different types of skin cancers. This system enables physicians to diagnose skin cancer at an earlier, more curable stage and reduce the number of biopsies needed, lower treatment costs. SCS is the sole owner of the related proprietary technology.

In June, mBeach Software announced its merger with Pomega, Inc., a cosmeceutical and nutraceutical company specializing in therapeutic skin care made with proprietary Omega 5 oil technology, sold under the Pomega5(R) brand. Capitalizing on the synergies between both companies, the acquisition would position MBHS as a leader in diagnostic skin health systems and topical aesthetic applications. Pomega, based in California, has emerged as a worldwide pioneer in developing the only line of skin care/skin rejuvenation products based on the therapeutic efficacy of pomegranate seed oil. Both Pomega and SCS are currently conducting clinical trials in the area of Omega 5 CLA (sourced from pomegranate seed oil), and in developing products for the aesthetic medicine industry, as well as cancer prevention and therapy. Pomega has relationships with large hotel chains, and their products are available at select spas, health/wellness stores nationwide and with select online retailers. The Company's Management team is committed to profitably increasing their revenue stream.

Southridge seeks investments in emerging growth areas, domestically and in international markets. Southridge has successfully participated in providing over $1.7 billion in capital to companies in the United States, Asia, Canada, the United Kingdom and Australia amongst other markets.

About Southridge

Southridge is a diversified financial holding company specializing in direct investment and advisory services to small and middle market issuers.

  Download PDF Version